
CGBIO_EN – CGBIO
CGBio will contribute to patients and medical practitioners around the world through sustained R&D investment to develop leading edge bio products. CGBio Inc, is a total healthcare provider with the goal of enhancing the quality of life by offering a range of innovative solutions for the whole spectrum of spinal disorders and wound management.
CGBIO - CGBIO
Easy-Tact / CG PASTE / Easyef / EasyefSaesalOintment / Fiblast / Scarsense-Alpha. Easydew Medical Device Cream / Easydew Medical Device Regen Cream. Aesthetic. GISELLELIGNE / VOM / FACETEM / Cellunit / Beluna / L-Derma / Easy-L-Mask / Easy-L-Hair. Dental. NovosisDent / CGDBM ALLOMIX / Bongener / DemiOS / Bongros.
国际事业部 - CGBIO CN
CGBIO是韩国领先的医疗器械制造商和供应商,为骨科和牙科提供各种症状的全伤口治疗材料和各种骨移植材料。 CGBIO一直致力于提供异体骨,DBM,合成骨,脊椎移植材料,负压伤口治疗技术,含生长因子的高级伤口敷料等高质量产品。 此外,CGBIO拥有100 clean rooms, purified water system等一流的设施以及精选的研究人员,产品的安全与稳定是CGBIO考虑的首要因素。 当代慢性病日益严重,需要持续进行临床数据库及技术创新的融合。 活跃的团体临床研究、复杂的 …
J&J MedTech signs exclusive distribution deal for CG Bio’s bone …
2025年2月6日 · Johnson & Johnson (J&J) MedTech, a global leader in the medical device industry, said it signed an exclusive distribution and promotional agreement with CG Bio and its affiliate CG MedTech for the NOVOSIS bone graft product.
CG Bio premieres ‘EGF Skin Booster’ at AMWC 2024
2024年4月5日 · CG Bio ran a booth at the event, showcasing its flagship products LUXX, Easy Dew EGF Skin Booster, PLA Tone Skin Booster, the calcium hydroxyapatite (CaHA) filler Facetem, and the hyaluronic acid (HA) filler Aileene, the company said.
医美 | 大熊制药:旗下婕尔"含麻版"玻尿酸正式获批上市
2022年10月25日,韩国大熊制药株式会社(DAEWOONG)旗下CG Bio Co., Ltd. 细基生物株式会社申报的“注射用交联透明质酸钠凝胶(型号:DANAE Contour,商品名:婕尔GISELLELIGNE)”成功获得国家药监局批准上市,国内代理人:北京大熊伟业医药科技有限公司,注册证号:国 ...
CG BIO 開物生醫| BRI 生物資源整合
cg bio建立了一系列安全高效的海藻產品生產體系,和國立臺灣海洋大學李孟洲老師與藻類培育暨生技實驗室團隊成員共同合作,專精於海藻藻種培養及機能性成分萃取。
CG Bio - Pyfaesthetic
Through extensive research activity, CG Bio is a leading manufacturer and distributor of comprehensive portfolio of allograft and synthetic bone grafts, spinal implants, GMP grade growth factors and total wound care solution.
CG Bio targets Chinese bone graft market with synthetic option …
2024年9月2日 · CG Bio, a Korean developer of regenerative medicine, said Monday that it plans to expand its market for bone graft materials in China by capitalizing on the rising demand for synthetic bone substitutes.
CG Bio Inc. - Manufacturer Of Allograft And Synthetic Bone Grafts ...
Through extensive research activity, CG Bio is a leading manufacturer and distributor of comprehensive portfolio of allograft and synthetic bone grafts, spinal implants, GMP grade growth factors and total wound care solution.